Pages that link to "Q53534081"
Jump to navigation
Jump to search
The following pages link to Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. (Q53534081):
Displaying 50 items.
- Pharmacologic neuroprotective strategies in neonatal brain injury (Q26852406) (← links)
- Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models (Q27000069) (← links)
- Animal modeling an oligodendrogliopathy--multiple system atrophy (Q28074659) (← links)
- Neuroprotective potential of erythropoietin in neonates; design of a randomized trial (Q31071784) (← links)
- Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat. (Q33605729) (← links)
- Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor (Q33666585) (← links)
- Angiogenesis, neurogenesis and brain recovery of function following injury (Q33718009) (← links)
- Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke (Q33787770) (← links)
- Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury (Q34056625) (← links)
- Trophic factors and stem cells for promoting recovery in stroke. (Q34240109) (← links)
- A longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxia (Q34285714) (← links)
- Role of oxidative stress and caspase 3 in CD47-mediated neuronal cell death (Q34600352) (← links)
- Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury (Q34829252) (← links)
- Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia (Q35042888) (← links)
- Multi-modal assessment of long-term erythropoietin treatment after neonatal hypoxic-ischemic injury in rat brain. (Q35154982) (← links)
- Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats (Q35194540) (← links)
- Elevated endogenous erythropoietin concentrations are associated with increased risk of brain damage in extremely preterm neonates (Q35202607) (← links)
- Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy (Q35471285) (← links)
- The role of cytokines and inflammatory cells in perinatal brain injury (Q35864361) (← links)
- Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics (Q36277628) (← links)
- Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair? (Q36385735) (← links)
- Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome (Q36420148) (← links)
- Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia-ischemia (Q36518208) (← links)
- Erythropoietin Modulates Cerebral and Serum Degradation Products from Excess Calpain Activation following Prenatal Hypoxia-Ischemia (Q36520524) (← links)
- Erythropoietin Ameliorates Neonatal Hypoxia-Ischemia-Induced Neurobehavioral Deficits, Neuroinflammation, and Hippocampal Injury in the Juvenile Rat (Q36743490) (← links)
- Acute and chronic vascular responses to experimental focal arterial stroke in the neonate rat. (Q36880813) (← links)
- Neuroprotective effects of erythropoietin in acute ischemic stroke (Q36917794) (← links)
- Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial (Q37098276) (← links)
- Migration of bone marrow‐derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarction (Q37295247) (← links)
- Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic (Q37307355) (← links)
- Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner (Q37392519) (← links)
- Erythropoietin 2nd cerebral protection after acute injuries: A double-edged sword? (Q37781871) (← links)
- Erythropoietin for neonatal brain injury: opportunity and challenge (Q37833284) (← links)
- New pharmacologic and therapeutic approaches for hypoxic-ischemic encephalopathy in the newborn (Q37981711) (← links)
- Inflammatory regulators of redirected neural migration in the injured brain (Q37997911) (← links)
- Neuroprotective role of erythropoietin in neonates (Q38041616) (← links)
- Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives (Q38172120) (← links)
- Implication of cord blood for cell-based therapy in refractory childhood diseases (Q38214093) (← links)
- Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease (Q38303586) (← links)
- Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy? (Q38387887) (← links)
- Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice (Q38629057) (← links)
- Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics (Q38927693) (← links)
- Function of neural stem cells in ischemic brain repair processes (Q38981287) (← links)
- Stem cell therapies in age-related neurodegenerative diseases and stroke (Q39017141) (← links)
- Therapeutic Strategies for Leukodystrophic Disorders Resulting from Perinatal Asphyxia: Focus on Myelinating Oligodendrocytes. (Q39404025) (← links)
- Mobilization of circulating progenitor cells following brain injury in premature neonates could be indicative of an endogenous repair process. A pilot study (Q39599753) (← links)
- Effects of Erythropoietin on Gliogenesis during Cerebral Ischemic/Reperfusion Recovery in Adult Mice (Q41108732) (← links)
- Erythropoietin Protects Against Lipopolysaccharide-Induced Microgliosis and Abnormal Granule Cell Development in the Ovine Fetal Cerebellum (Q41160147) (← links)
- Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial. (Q41469526) (← links)
- Increased Brain Perfusion Persists over the First Month of Life in Term Asphyxiated Newborns Treated with Hypothermia: Does it Reflect Activated Angiogenesis? (Q41527936) (← links)